Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299441 · ClinicalTrials.gov registry record
Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 40
- Enrollment target
NCT01299441: Clinical Trial study, sponsored by Mayo Clinic.
NCT01299441 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01299441 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.
Interventions
- DEVICE ECOM ETT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-02 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01299441
The ClinicalTrials.gov registry entry for NCT01299441 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ECOM ETT is the first listed.
NCT01299441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01299441 about?
NCT01299441 is a clinical study titled "Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation". The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.
What is the current status of trial NCT01299441?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2011-02. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01299441?
The interventions under investigation include: ECOM ETT (DEVICE).
Who is sponsoring clinical trial NCT01299441?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.